Literature DB >> 8797872

Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspirates.

T Sugino1, K Yoshida, J Bolodeoku, H Tahara, I Buley, S Manek, C Wells, S Goodison, T Ide, T Suzuki, E Tahara, D Tarin.   

Abstract

We analysed telomerase activity in normal, benign and malignant breast tissues and in fine needle aspirates by a PCR-based assay. The tissue samples we used in this assay consisted of 20 cryostat sections, 10 microns thick, from each breast biopsy. This method was used to obtain effective extraction from small samples and to confirm the histological identity of the specimen by microscopical examination of serial sections. Fifty-two of 71 breast carcinomas were positive for telomerase activity, and the intensity of this was strong in most cases, whereas all 6 samples of normal breast tissue and 17 of fibrocystic disease were negative and only 1 of 15 fibroadenomas was positive. Invasive ductal carcinomas were more frequently positive than invasive lobular carcinomas. There was no correlation of telomerase activity with tumour size or the occurrence of lymph node metastasis. Evaluation of our assay system showed that a signal of telomerase activity was detectable in extracts from single cryostat sections (< 1 mm2) of a cancer specimen and from as few as 4 cells of a human breast cancer cell line. On the basis of the above data, we applied this assay to fine needle aspirates of breast lesions. Ten of 15 aspirates which had been cytopathologically diagnosed as cancer were strongly positive, while 26 of 29 benign aspirates were totally negative and the remaining 3 showed only borderline activity. In 3 cases, the telomerase result could have helped establish a diagnosis when the cytological observations were inconclusive. Our results indicate that this sensitive assay could become a useful new modality for supplementing microscopic cytopathology in the detection of cancer cells in small tissue biopsies and fine needle aspirates.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797872     DOI: 10.1002/(SICI)1097-0215(19960822)69:4<301::AID-IJC11>3.0.CO;2-8

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Telomerase activity in human gynaecological malignancies.

Authors:  H Gorham; K Yoshida; T Sugino; G Marsh; S Manek; M Charnock; D Tarin; S Goodison
Journal:  J Clin Pathol       Date:  1997-06       Impact factor: 3.411

Review 2.  Telomerase in the early detection of cancer.

Authors:  J W Shay; A F Gazdar
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

3.  Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.

Authors:  K Yoshida; T Sugino; S Goodison; B F Warren; D Nolan; S Wadsworth; N J Mortensen; T Toge; E Tahara; D Tarin
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  A non-isotopic method for the detection of telomerase activity in tumour tissues: TRAP-silver staining assay.

Authors:  J M Wen; L B Sun; M Zhang; M H Zheng
Journal:  Mol Pathol       Date:  1998-04

5.  A study on telomerase activity and prognosis in breast cancer.

Authors:  M Kimura; T Koida; Y Yanagita
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

Review 6.  Culture models of human mammary epithelial cell transformation.

Authors:  M R Stampfer; P Yaswen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

7.  Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.

Authors:  Tomoko Ozawa; Sergei M Gryaznov; Lily J Hu; Krisztina Pongracz; Raquel A Santos; Andrew W Bollen; Kathleen R Lamborn; Dennis F Deen
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

8.  Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype.

Authors:  Ana Kulić; Natalija Dedić Plavetić; Stjepan Gamulin; Jasminka Jakić-Razumović; Damir Vrbanec; Maja Sirotković-Skerlev
Journal:  Med Oncol       Date:  2016-01-30       Impact factor: 3.064

Review 9.  Telomeres and telomerase in endocrine pathology.

Authors:  G Kontogeorgos; K Kovacs
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

10.  Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues.

Authors:  J T Chang; C T Liao; S M Jung; T C Wang; L C See; A J Cheng
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.